Evidence map›Paper›PMID 26376898›Full record

ReviewImmunologic research2015

Immunological function of Blimp-1 in dendritic cells and relevance to autoimmune diseases.

Sun Jung Kim

Open access · greenAbstract readReview
In one paragraph

Review in Immunologic research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Research Progress of Plasma Cell Mastitis.Immunity, inflammation and disease · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Genome-wide studies define new genetic mechanisms of IgA vasculitis.medRxiv : the preprint server for health sciences · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. HMGB1 in Systemic Lupus Erythematosus.Frontiers in immunology · 2020
    Review
  18. Insights Into the Evolution of theFrontiers in immunology · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sun Jung KimCenter for Autoimmune and Musculoskeletal Disease, The Feinstein Institute for Medical Research, Manhasset, NY, 11030, USA. sjkim@nshs.edu.
Feinstein Institute for Medical Research · US

Funding

The Blimp-1 SLE risk variant regulates inflammatory function in dendritic cellsR01AR065209 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KIM, SUN JUNG · 2014 to 2017
$1.8M
Function of Blimp1/prdm-1 in dendritic cells in the generation of autoantibodiesK01AR059378 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI KIM, SUN JUNG · 2010 to 2014
$568k
NIAMS NIH HHS K01 AR059378NIAMS NIH HHS K01 AR59378NIAMS NIH HHS R01 AR065209
6 · The paper itself

Abstract

Previous studies have identified the immunological functions of transcription factor B lymphocyte-induced maturation protein-1 (Blimp-1) in various adaptive immune cell types such as T and B lymphocytes. More recently, it has been shown that Blimp-1 extends its functional roles to dendritic cells (DCs) and macrophages, two cell types belonging to the innate immune system. The protein acts as a direct and indirect regulator of target genes by recruiting chromatin modification factors and by regulating microRNA expression, respectively. In DCs, Blimp-1 has been identified as one of the components involved in antigen presentation. Genome-wide association studies identified polymorphisms associated with multiple autoimmune diseases such as system lupus erythematosus, rheumatoid arthritis, and inflammatory bowel disease in PRDM1, the gene encoding Blimp-1 protein. In this review, we will discuss the immune regulatory functions of Blimp-1 in DCs with a main focus on the tolerogenic mechanisms of Blimp-1 required to protect against the development of autoimmune diseases.

Indexed as

AnimalsAntigen PresentationAutoimmune DiseasesDendritic CellsGene Expression RegulationGenetic Predisposition to DiseaseHumansImmune ToleranceImmunityMicroRNAsPolymorphism, GeneticPositive Regulatory Domain I-Binding Factor 1Repressor ProteinsMicroRNAsPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanRepressor ProteinsAntigen presentationBlimp-1Dendritic cellsSLE

Identifiers

PMID26376898
PMCPMC4651792
OpenAlexW1707612224

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.